Literature DB >> 33415138

The Effect of Strontium Ranelate on Fracture Healing: An Animal Study.

Ourania I Koukou1, Lampros D Pappas2, Pelagia Chloropoulou3, Maria A Kouroupi4, Konstantinos I Koukos5, Georgia Karpathiou6, Antonios A Galanos7, Georgios I Drosos8, Evaggelos Magnisalis9, Alexandra N Giatromanolaki4, Dionysios Alexandros Verettas10.   

Abstract

BACKGROUND: Strontium ranelate (StR) is an antiosteoporotic agent previously utilized for the enhancement of fracture union. We investigated the effects of StR on fracture healing using a rabbit model.
METHODS: Forty adult female rabbits were included in the study and were divided in 2 equal groups, according to StR treatment or untreated controls. All animals were subjected to osteotomy of the ulna, while the contralateral ulna remained intact and served as a control for the biomechanical assessment of fracture healing. Animals in the study group received 600 mg/kg/day of StR orally. All animals received ordinary food. At 2 and 4 weeks, all animals were euthanatized and the osteotomy sites were evaluated for healing through radiological, biomechanical, and histopathological studies.
RESULTS: The treatment group presented statistically significant higher callus diameter, total callus area, percentage of fibrous tissue (p < 0.001), vessels/mm2, number of total vessels, and lower osteoclast number/mm2 (p < 0.05) than the control group at 2 weeks. Additionally, the treatment group presented significantly higher percentages of new trabecular bone, vessels/mm2, osteoclast number/mm2, and lower values for callus diameter, as well as total callus area (p < 0.05), than the control group at 4 weeks. At 4 weeks, in the treatment group, force applied (p = 0.003), energy at failure (p = 0.004), and load at failure (p = 0.003) were all significantly higher in the forearm specimens with the osteotomized ulnae compared to those without. Radiological bone union was demonstrated for animals receiving StR at 4 weeks compared with controls (p = 0.045).
CONCLUSION: StR appears to enhance fracture healing but further studies are warranted in order to better elucidate the mechanisms and benefits of StR treatment.
Copyright © 2020 Ourania I. Koukou et al.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33415138      PMCID: PMC7768587          DOI: 10.1155/2020/1085324

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  48 in total

1.  S 12911-2 inhibits osteoclastic bone resorption in vitro.

Authors:  N Takahashi; T Sasaki; Y Tsouderos; T Suda
Journal:  J Bone Miner Res       Date:  2003-06       Impact factor: 6.741

2.  Strontium Ranelate and bone healing: report of two cases.

Authors:  Umberto Tarantino; Monica Celi; Luca Saturnino; Alessandro Scialdoni; Irene Cerocchi
Journal:  Clin Cases Miner Bone Metab       Date:  2010-01

Review 3.  Fracture healing: mechanisms and interventions.

Authors:  Thomas A Einhorn; Louis C Gerstenfeld
Journal:  Nat Rev Rheumatol       Date:  2014-09-30       Impact factor: 20.543

4.  Strontium ranelate as an adjuvant for fracture healing: clinical, radiological, and ultrasound findings in a randomized controlled study on wrist fractures.

Authors:  M Scaglione; L Fabbri; F Casella; G Guido
Journal:  Osteoporos Int       Date:  2015-08-21       Impact factor: 4.507

5.  Short-term effects of fluoride and strontium on bone formation and resorption in the mouse.

Authors:  P J Marie; M Hott
Journal:  Metabolism       Date:  1986-06       Impact factor: 8.694

6.  Effects of low doses of strontium on bone quality and quantity in rats.

Authors:  M D Grynpas; P J Marie
Journal:  Bone       Date:  1990       Impact factor: 4.398

7.  Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration.

Authors:  G Boivin; P Deloffre; B Perrat; G Panczer; M Boudeulle; Y Mauras; P Allain; Y Tsouderos; P J Meunier
Journal:  J Bone Miner Res       Date:  1996-09       Impact factor: 6.741

8.  The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro.

Authors:  E Canalis; M Hott; P Deloffre; Y Tsouderos; P J Marie
Journal:  Bone       Date:  1996-06       Impact factor: 4.398

9.  PTH (1-34), but not strontium ranelate counteract loss of trabecular thickness and bone strength in disuse osteopenic rats.

Authors:  Annemarie Brüel; Jens Bay Vegger; Anders Christer Raffalt; Jens Enevold Thaulov Andersen; Jesper Skovhus Thomsen
Journal:  Bone       Date:  2012-12-11       Impact factor: 4.398

10.  Strontium ranelate does not stimulate bone formation in ovariectomized rats.

Authors:  R K Fuchs; M R Allen; K W Condon; S Reinwald; L M Miller; D McClenathan; B Keck; R J Phipps; D B Burr
Journal:  Osteoporos Int       Date:  2008-04-03       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.